Diana Levina, MD
Geriatric Medicine · Brooklyn, NYNPI 1114017472
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Boehringer Ingelheim at 35.1% of the total. 2025 is the largest year on record at $2,357, 2.4 times the $973 reported in 2019. Among geriatric medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $123.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$3K
- Amgen$2K
- AstraZeneca$835
- AbbVie$520
- Lilly USA, LLC$371
- Aimmune Therapeutics, Inc.$250
- plus $2K from 15 others
What the payments were for
- Food & beverage$8,991100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 26 | $3,156 |
| Amgen | 12 | $1,586 |
| AstraZeneca | 7 | $835 |
| AbbVie | 5 | $520 |
| Lilly USA, LLC | 3 | $371 |
| Aimmune Therapeutics, Inc. | 2 | $250 |
| Merck | 2 | $250 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $248 |
| Pharmacosmos Therapeutics Inc. | 2 | $247 |
| Beigene USA, Inc. | 1 | $150 |
| Ardelyx, Inc. | 1 | $140 |
| Beone Medicines USA, Inc. | 1 | $135 |
| Alkermes, Inc. | 1 | $130 |
| Medtronic | 1 | $127 |
| Pfizer | 1 | $125 |
| Avanir Pharmaceuticals, Inc. | 1 | $125 |
| Dova Pharmaceuticals | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Eisai Inc. | 1 | $112 |
| Sanofi | 1 | $109 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,991 in reported general payments places this provider in the 95th percentile of 400 geriatric medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 76 | $22,572 |
| SantylCollagenase Clostridium Hist. | 14 | $17,111 |
| JanuviaSitagliptin Phosphate | 33 | $9,457 |
| RayaldeeCalcifediol | 11 | $6,906 |
| XareltoRivaroxaban | 15 | $4,248 |
| Enoxaparin Sodium | 25 | $1,780 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 11 | $1,114 |
| Tamsulosin Hcl | 44 | $527 |
| Atorvastatin Calcium | 44 | $454 |
| Levetiracetam | 24 | $427 |
| Levothyroxine Sodium | 36 | $331 |
| Pantoprazole Sodium | 36 | $288 |
| Mirtazapine | 23 | $284 |
| Buspirone Hcl | 25 | $272 |
| Metoprolol Tartrate | 24 | $190 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $125 | $22,57276 claims |
| MerckJanuvia | $250 | $9,45733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 400 geriatric medicine providers in New York.
Other geriatric medicine in Brooklyn
- Wen DombrowskiBrooklyn$45K
- Inna ShifrinBrooklyn$21K
- Sergey GenkinBrooklyn$10K
- Faina KoganBrooklyn$7K
- William PutmanBrooklyn$6K
- Roberto RobinsonBrooklyn$6K
- Nathalia IdelevitchBrooklyn$5K
- Stefano FrancoBrooklyn$3K
- Larissa GoldBrooklyn$3K
- Howard OrkinBrooklyn$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.